StockWatch
·
Filing
Q4

HESTER BIOSCIENCES LTD.

HESTERBIOFY2509 May 2025
Revenue+29.6%
Net Profit-86.5%
OPM23.41%

P&L

Quarterly Consolidated

Revenue
+29.6%81.92
Expenditure
+23.7%72.54
Net Profit
-86.5%1.54
NPM 2.06%-86.0%EPS ₹1.82-86.4%

vs Q3 FY25

Hester Biosciences Reports 17% Profit Growth, Declares 70% Dividend for FY25

09 May 2025 · 9 May 2025, 05:29 pm

Summary

Hester Biosciences Ltd. has reported a 17% growth in profit for the financial year 2024-25 and has declared a dividend of 70%. The company's standalone and consolidated financial results for the quarter and year ended 31 March 2025 have been approved in the recent Board Meeting. The company has also appointed Shah & Shah Associates, Company Secretaries, Ahmedabad as the Secretarial Auditors for a period of five consecutive years from FY 2025-26 to FY 2029-30.

Key Highlights

  1. 1

    Hester Biosciences reports a 17% growth in profit for FY25

  2. 2

    The company declares a dividend of 70% for the financial year 2024-25

  3. 3

    Standalone and consolidated financial results for Q4 & FY25 approved

  4. 4

    Shah & Shah Associates appointed as Secretarial Auditors for five years

Management Comments

N

Not specified

Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2025, as recommended by Audit Committee and the Audited Standalone and Consolidated Financial Statements for the year ended 31 March 2025. Pursuant to Regulation 33 (3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended time to time), we hereby state that the Statutory Auditors of the Company, Chandulal M. Shah & Co., Chartered Accountants (FRN: 101698W) have issued an Audit Report with unmodified opinion on the Audited Standalone and Consolidated Financial Results of the Company for the financial year ended on 31 March 2025. 2. Recommended dividend of %7 (Seven) per equity share of 10 each (70%) for the financial year 2024-25, subject to approval of members at the ensuing Annual General Meeting. 3. Appointment of Shah & Shah Associates, Company Secretaries, Ahmedabad, as a Secretarial Auditors for a period of five consecutive years from FY 2025-26 to FY 2029-30, as recommended by Audit Committee, subject to approval of members at the ensuing annual general meeting.

Informational and educational content only. Not investment advice.